The Influenza vaccines market
represent an attractive market characterize by sturdy growth
prospects. Increasing awareness, growing vaccination coverage in the
emerging countries, rising government support for immunization
against Seasonal Influenza and increased focus on the production of
treatments for vulnerable populations by introducing new vaccines and
vaccines with a better route of administration are the main drivers
to galvanized Influenza vaccines market.
View Full Report at
http://www.marketresearchreports.biz/analysis/232452
Seasonal Influenza vaccines
market has Billions US$ market in 2013. Seasonal Influenza vaccines
market is expected to grow with double digit percentage from 2013 to
2019. On the other hand, H1N1 Influenza vaccines market has seen
tremendous growth during 2009 and 2010 primarily driven by the global
spread of H1N1 Influenza virus. However, strong demand of Influenza
vaccines contracted in 2011 by more than 50% due to waning threat of
swine flu epidemic.
United States remains the
largest market for Seasonal Influenza vaccines. Japan and emerging
countries like China, India and Brazil is likely to drive Influenza
vaccines markets in the next 5 to 6 years. Netherlands and United
Kingdom have achieved greater vaccinations coverage.
Download Detail Report With
Complete TOC at
http://www.marketresearchreports.biz/sample/sample/232452
In the major Seasonal
Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the
highest sales figures and likely to maintain leadership position in
the Seasonal Influenza vaccines market.
- Worldwide Influenza vaccines market (2009 - 2019)
- Worldwide Seasonal Influenza vaccines market has been covered from (2009 – 2019)
- Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 – 2011)
- Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
- Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
- Top 30 countries Seasonal Influenza vaccines market (2008 – 2019)
- Top Brands Seasonal Influenza vaccines (Fluarix/Flulaval, Afluria/Fluvax, FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast
- Top Merger & Acquisition deals in Influenza Vaccines Market
- Key drivers of growth in the Worldwide Influenza Vaccines Market
- Key challenges faces by Influenza Vaccines Market
All
the 30 Countries Studied in the Report are as Follows
- United States
- Japan
- China
- India
- Brazil
- Netherlands
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Portugal
- Luxembourg
- Lithuania
- United Kingdom
- Poland
- Norway
- Romania
- Estonia
- Finland
- Hungary
- Ireland
- Iceland
- Latvia
- Malta
- Slovakia
- Slovenia
- Australia
- New Zealand
Top
6 Seasonal Influenza Vaccines Sales Performance Studied in the Report
are as Follows
- Fluarix / Flulaval
- Afluria/Fluvax
- FluMist/Fluenz
- Influvac
- Fluvirin / Flucelvax
- Fluzone
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
No comments:
Post a Comment